Kathleen Sebelius Insider Profile

4 Followers
Kathleen Sebelius, Director at Dermira, holds 6.00K shares in Dermira (Ticker: ~DERM), holds 41.21K shares in Humacyte (Ticker: HUMA), holds 31.89K shares in Exact Sciences (Ticker: EXAS). Most recently, Kathleen Sebelius ― shares of Dermira on ― for an estimated value of ―.
tipranks
Kathleen Sebelius

Kathleen Sebelius
Dermira (~DERM)
Director

Ranked #30,427 out of 98,834 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+47.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
89.80%
8.95%
1.25%
A breakdown of Kathleen Sebelius's holdings

Insider Roles

Exact Sciences
(EXAS)
Director
Humacyte
(HUMA)
Director
Journey Medical Corp
(DERM)
Director
Roles that Kathleen Sebelius holds in companies

Most Profitable Insider Trade

Stock:
Myovant Sciences
(MYOV)
Rating:Informative Buy
Date:Jun 14, 2019 - Jun 14, 2020
Return:+93.50%
The most profitable trade made by Kathleen Sebelius

Kathleen Sebelius's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
~DERM
Dermira
$112.50K
MYOV
Myovant Sciences
Jun 14, 2019
Informative Buy
44.78K
$134.90K
Exact Sciences
Jun 17, 2024
Director
Uninformative Buy
$2.21M
Humacyte
Sep 11, 2024
Director
Uninformative Buy
27.93K
$220.05K
Journey Medical Corp
Director
$30.72K
List of latest transactions for each holding click on a transaction to see Kathleen Sebelius's performance on stock

Kathleen Sebelius insider profile FAQ

What is the percentage of profitable transactions made by Kathleen Sebelius?
The percentage of profitable transactions made by Kathleen Sebelius is 100%.
    What is the average return per transaction made by Kathleen Sebelius?
    The average return per transaction made by Kathleen Sebelius is 47.10%.
      What stocks does Kathleen Sebelius hold?
      Kathleen Sebelius holds: ~DERM, MYOV, EXAS, HUMA, DERM stocks.
        What was Kathleen Sebelius’s latest transaction?
        Kathleen Sebelius latest transaction was an Uninformative Buy of ―.
          What was Kathleen Sebelius's most profitable transaction?
          Kathleen Sebelius’s most profitable transaction was an Informative Buy of MYOV stock on June 14, 2019. The return on the trade was 93.50%.
            What is Kathleen Sebelius's role in Dermira?
            Kathleen Sebelius's role in Dermira is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.